#catalyst pharmaceutical

Catalyst Pharmaceutical (CPRX): Q3 2019 Earnings Snapshot

—  Catalyst Pharmaceutical (NASDAQ: CPRX) reported third quarter 2019 earnings of of $0.13 per share, vs. $0.11 per share expected.

— Net product revenue came in at $30.9 million, vs. $33.2 million expected.

— Expects full year 2019 revenues of approx. $100 million. Revenues in 2020 projected to be in the range of $135 million to $155 million.

— CPRX shares fell 5.2% immediately…